Insulin resistance in people with multiple sclerosis
Part of Brain & nervous system, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how common insulin resistance (when your body doesn't use insulin well) is in people with multiple sclerosis (MS). It involves a blood sample and may help doctors understand more about how MS affects your body's metabolism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 to 50 years old
- Must have a confirmed diagnosis of multiple sclerosis (any type)
- No MS relapses or steroid use in the last 3 months
- Must not have diabetes, high blood pressure, heart disease, liver or kidney disease, or a history of alcohol abuse
- Must not be on a special diet or taking certain medications that affect metabolism
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults over time to understand how weight and body chemistry relate to insulin resistance. It may help researchers learn why insulin resistance happens and what could prevent or improve it.
This trial tests if a GLP-1 receptor agonist can help people with multiple sclerosis who have a high BMI. It may reduce inflammation and improve health.
This study looks at how insulin affects blood vessels in people with obesity compared to healthy weight adults. It may help understand why obesity increases heart disease risk.
This research study examines how muscle cells handle blood sugar differently depending on whether someone is lean or has obesity, and whether their body resists insulin. Researchers will take small muscle samples to understand the genetic differences, which may help develop better treatments for insulin resistance and metabolic health.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
This study looks at how the body handles insulin in people who are insulin resistant. You will receive a special procedure called a pancreatic clamp to measure insulin sensitivity, which may help researchers understand and treat insulin resistance better.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.